KEY FEATURES
| Full Name | Connective Tissue Growth Factor |
|---|---|
| Synonym | CCN2; HCS24; IGFBP8; NOV2; Insulin-Like Growth Factor-Binding Protein 8; Hypertrophic Chondrocyte-Specific Protein 24; CCN Family Member 2 |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 0.78-50ng/mL |
| Sensitivity | 0.32ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human CTGF in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human CTGF. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human CTGF and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human CTGF, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human CTGF. You can calculate the concentration of Human CTGF in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human CTGF ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 2.56 | 7.33 | 22.9 | 2.52 | 7.5 | 22.4 |
| Standard deviation | 0.14 | 0.3 | 0.76 | 0.14 | 0.38 | 1.1 |
| CV(%) | 5.54 | 4.12 | 3.33 | 5.55 | 5.12 | 4.91 |
RECOVERY
The recovery of Human CTGF spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 94-107 | 99 |
| EDTA plasma (n=8) | 88-100 | 93 |
| Cell culture media (n=8) | 95-109 | 102 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human CTGF in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with NOV ELISA Kits
| BMP2 ELISA Kit | publications with NOV and BMP2 |
| TEC ELISA Kit | publications with NOV and TEC |
| MUSK ELISA Kit | publications with NOV and MUSK |
| GJA1 ELISA Kit | publications with NOV and GJA1 |
| DDR1 ELISA Kit | publications with NOV and DDR1 |
| PLXNA1 ELISA Kit | publications with NOV and PLXNA1 |
Pathways associated with NOV ELISA Kit
| Delta-Notch Signaling Pathway | Delta-Notch Signaling Pathway |
Diseases associated with NOV ELISA Kit
| Nervous System Diseases | publications with NOV and Nervous System Diseases |
| Cardiovascular Diseases | publications with NOV and Cardiovascular Diseases |
| Vascular Diseases | publications with NOV and Vascular Diseases |
| Heart Diseases | publications with NOV and Heart Diseases |
| Carcinoma | publications with NOV and Carcinoma |
| Inflammation | publications with NOV and Inflammation |
| Kidney Diseases | publications with NOV and Kidney Diseases |
| Hypertension | publications with NOV and Hypertension |
| Adenocarcinoma | publications with NOV and Adenocarcinoma |
| Necrosis | publications with NOV and Necrosis |
Organs/Tissues associated with NOV ELISA Kit
| Blood | publications with NOV and Blood |
| Brain | publications with NOV and Brain |
| Heart | publications with NOV and Heart |
| Vascular | publications with NOV and Vascular |
| Bone | publications with NOV and Bone |
| Liver | publications with NOV and Liver |
| Muscle | publications with NOV and Muscle |
| Kidney | publications with NOV and Kidney |
| Lung | publications with NOV and Lung |
| Skin | publications with NOV and Skin |